| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $64.9M | — | -6.7% |
| Cost of Revenue | $20.5M | — | -2.5% |
| Gross Profit | $44.4M | — | -8.5% |
| R&D Expense | $1.1M | — | +10.4% |
| SG&A Expense | $21.9M | — | -34.6% |
| Operating Income | -$1.8M | — | +85.0% |
| Pre-tax Income | -$6.8M | — | +26.0% |
| Income Tax | -$184K | — | -120.6% |
| Net Income | -$6.6M | — | +34.3% |
| EPS (Basic) | -$0.05 | — | +37.5% |
| EPS (Diluted) | -$0.05 | — | +37.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Accounts Receivable | $18.6M | -14.4% | -20.0% |
| Inventory | $47.7M | -0.7% | -27.3% |
| Current Assets | $277.7M | -10.3% | -40.8% |
| Total Assets | $473.2M | -5.3% | -29.8% |
| Current Liabilities | $155.2M | -16.7% | +147.1% |
| Total Liabilities | $418.0M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$5.6M | — | -285.4% |
| Capital Expenditures | $224K | — | +397.8% |
| Investing Cash Flow | -$1.6M | — | -44.0% |
| Financing Cash Flow | -$20.9M | — | -8262.4% |
| Free Cash Flow | -$5.8M | — | -295.8% |
| -33.4% |
| Stockholders' Equity | $55.2M | -9.5% | +19.9% |